Create SD Holdings Co., Ltd. (JP:3148)
:3148
Top Page
Create SD Holdings Co., Ltd.
(3148)
Select Model
Select Model
Rating:75Outperform
Price Target:
¥3,758.00
▲(12.51% Upside)
Action:ReiteratedDate:01/04/26
The score is driven primarily by strong financial safety (debt-free balance sheet and stable ROE) alongside steady growth, tempered by thin margins and volatile free-cash-flow conversion. Technicals add support with price above key moving averages and moderate positive momentum, while valuation is reasonable with a moderate P/E and a ~2.4% dividend yield.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and stability.
Negative Factors
Free Cash Flow Conversion
Inefficient cash conversion may limit the company's ability to reinvest in operations or distribute returns, potentially hindering growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and stability.
Read all positive factors
Create SD Holdings Co., Ltd. (3148) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥214.63B
Dividend Yield2.35%
Average Volume (3M)76.12K
Price to Earnings (P/E)12.7
Beta (1Y)0.30
Revenue Growth7.55%
EPS Growth16.01%
CountryJP
Employees4,797
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)66.87
Shares Outstanding66,819,340
10 Day Avg. Volume114,270
30 Day Avg. Volume76,116
Financial Highlights & Ratios
PEG Ratio1.03
Price to Book (P/B)1.43
Price to Sales (P/S)0.45
P/FCF Ratio33.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Create SD Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Create SD Holdings Co., Ltd., through its subsidiaries, engages in drug store, dispensing pharmacy, and nursing care businesses in Japan. The company sells pharmaceuticals, cosmetics, food products, daily goods, etc. It also operates and manages n...
How the Company Makes Money
Create SD Holdings Co., Ltd. generates revenue primarily through the sale of products in its chain of drugstores. The company earns money by purchasing goods from suppliers at wholesale prices and selling them at retail prices to consumers. Key re...
Create SD Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
90
Very Positive
Cash Flow
58
Neutral
| Breakdown | TTM | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 464.78B | 457.09B | 422.33B | 380.96B | 350.74B | 338.48B |
| Gross Profit | 120.87B | 119.22B | 110.19B | 102.99B | 95.58B | 93.37B |
| EBITDA | 28.26B | 27.66B | 24.35B | 23.01B | 22.02B | 21.73B |
| Net Income | 16.26B | 15.69B | 13.69B | 12.93B | 12.60B | 12.38B |
Balance Sheet | ||||||
| Total Assets | 234.51B | 236.56B | 216.48B | 194.94B | 176.91B | 163.82B |
| Cash, Cash Equivalents and Short-Term Investments | 35.44B | 37.75B | 38.21B | 37.53B | 42.07B | 39.28B |
| Total Debt | 0.00 | 0.00 | 1.00M | 6.00M | 25.00M | 63.00M |
| Total Liabilities | 90.66B | 93.84B | 86.24B | 78.53B | 70.58B | 67.19B |
| Stockholders Equity | 143.85B | 142.72B | 130.24B | 116.41B | 106.32B | 96.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.10B | 5.26B | 3.03B | 8.63B | 4.17B |
| Operating Cash Flow | 0.00 | 23.63B | 21.03B | 18.98B | 16.10B | 11.57B |
| Investing Cash Flow | 0.00 | -20.70B | -20.21B | -20.49B | -10.81B | -10.42B |
| Financing Cash Flow | 0.00 | -3.39B | -140.00M | -3.03B | -2.91B | -2.65B |
Create SD Holdings Co., Ltd. Technical Analysis
Positive
3340.00
Price Trends
3297.10
Positive
3297.49
Positive
3291.97
Positive
Market Momentum
22.98
Negative
63.31
Neutral
84.92
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3148, the sentiment is Positive. The current price of 3340 is above the 20-day moving average (MA) of 3287.75, above the 50-day MA of 3297.10, and above the 200-day MA of 3291.97, indicating a bullish trend. The MACD of 22.98 indicates Negative momentum. The RSI at 63.31 is Neutral, neither overbought nor oversold. The STOCH value of 84.92 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3148.
Create SD Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥214.63B | 12.71 | ― | 2.35% | 7.55% | 16.01% | |
69 Neutral | ¥459.04B | 14.05 | 11.37% | 3.04% | 6.32% | 8.19% | |
67 Neutral | ¥366.97B | 16.82 | ― | 0.41% | 15.81% | 27.05% | |
66 Neutral | ¥677.19B | 23.29 | 15.71% | 0.96% | 21.81% | 67.76% | |
62 Neutral | ¥1.01T | 19.41 | ― | 1.72% | ― | ― | |
60 Neutral | ¥524.40B | 22.79 | ― | 0.93% | 3.73% | 18.84% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:3148
Create SD Holdings Co., Ltd.
3,395.00
517.30
17.98%
JP:9989
Sundrug Co
3,926.00
-457.11
-10.43%
JP:7649
Sugi Holdings Co
3,593.00
565.97
18.70%
JP:3391
TSURUHA Holdings
2,250.00
113.69
5.32%
JP:3349
COSMOS Pharmaceutical Corporation
6,588.00
-1,475.88
-18.30%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,838.00
650.88
20.42%
Create SD Holdings Co., Ltd. Corporate Events
Create SD Holdings Delivers Higher First-Half Profits, Raises Dividend and Expands Group
Jan 13, 2026
Create SD Holdings reported solid growth for the six months ended November 30, 2025, with net sales rising 7.6% year on year to ¥241.9 billion and profit attributable to owners of the parent increasing 12.3% to ¥7.9 billion, supported by...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.